Host populations, challenges, and commercialization of cryptococcal vaccinesShow full item record
|Title||Host populations, challenges, and commercialization of cryptococcal vaccines|
|Author||Poeta M. D.; Wormley F. L.; Lin X.|
|Abstract||AU Vaccines: Pleaseconfirmthatallheadinglevelsarerepresentedcorrectly are one of the most effective public health tools to:prevent and manage infectious diseases. Since the first clinical use of vaccines in the late 18th century, many vaccines have been successfully developed to combat bacterial and viral infections, including the most recent Coronavirus Disease 2019 (COVID-19) pandemic. However, there remains no vaccine that is clinically available to treat or prevent invasive fungal diseases, including cryptococcal meningoencephalitis. This fungal disease is uniformly fatal without treatment and has a global mortality rate of over 70%. Despite a dire need for an effective cryptococcal vaccine, there are many scientific and economic challenges to overcome prior to making it a reality. Here, we discuss some of these challenges as well as steps that the community is taking for commercialization of effective cryptococcal vaccines. Copyright: ¿ 2023 Del Poeta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
health care cost
Human immunodeficiency virus infection
Files in this item
This item appears in the following Collection(s)
- Research Publications 
Showing a few items related by title, author, creator and subject.
Comparison of Commercial Negotiated Price and Cash Price between Physician-Owned Hospitals and Other Hospitals in the Same Hospital Referral Region Wang Y.; Plummer E.; Wang Y.; Cram P.; Bai G. (2023)Understanding how physicians' ownership of hospitals affects patients and payers is an important research area. Prior research has focused on differences in quality between physician-owned hospitals (POHs) and other ...
Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer by Suppressing the HER2/AKT Signaling Pathway Zhang W.; Bhagwath A.S.; Ramzan Z.; Williams T.A.; Subramaniyan I.; Edpuganti V.; Kallem R.R.; Dunbar K.B.; Ding P.; Gong K.; Geurkink S.A.; Beg M.S.; Kim J.; Zhang Q.; Habib A.A.; Choi S.-H.; Lapsiwala R.; Bhagwath G.; Dowell J.E.; Melton S.D.; Jie C.; Putnam W.C.; Pham T.H.; Wang D.H. (2021)Itraconazole, an FDA-approved antifungal, has antitumor activity against a variety of cancers. We sought to determine the effects of itraconazole on esophageal cancer and elucidate its mechanism of action. Itraconazole ...
Does individual advocacy work?: A research and evaluation protocol for a youth anti-sex trafficking program Twis, Mary K.; Cimino, A.; Files, M. (2022)Introduction Thousands of youth are sexually trafficked each year worldwide. Increased public attention to the commercial sexual exploitation (CSE) of children has resulted in the rapid deployment of hybrid community public ...